Published • loading... • Updated
Remix Therapeutics Appoints Nicole Sweeny as Chief Commercial Officer
Summary by Citybiz
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Remix Therapeutics Appoints Nicole Sweeny as Chief Commercial Officer
Remix Therapeutics has appointed Nicole Sweeny as chief commercial officer, adding an executive with more than 20 years of biopharma commercialization experience as the Watertown, Massachusetts-based company advances its clinical pipeline and builds capabilities to support potential future product launches. Sweeny joins the clinical-stage biotechnology company after serving as chief commercial officer at KalVista Pharmaceuticals, where she built…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
